Literature DB >> 1317909

Atrial natriuretic factor improves renal function and lowers systolic blood pressure in renal allograft recipients treated with cyclosporin A.

C C Lang1, I S Henderson, R Mactier, W K Stewart, A D Struthers.   

Abstract

OBJECTIVE: Atrial natriuretic factor (ANF) has several properties which suggest that it may ameliorate cyclosporin A nephrotoxicity. We therefore investigated the response to a pharmacological dose of ANF in renal transplant recipients treated with cyclosporin A.
DESIGN: A single-blind randomized crossover design comparing the renal and haemodynamic effects of D-glucose (placebo) with ANF.
METHODS: Seven patients with stable renal function following renal transplantation were studied under maximal water diuresis. Glomerular filtration rate and effective renal plasma flow were estimated from clearances of inulin and para-aminohippurate, respectively.
RESULTS: Plasma ANF levels increased significantly in association with increased diuresis and natriuresis. Glomerular filtration rate was unchanged after placebo but increased significantly after ANF fusion. Likewise, effective renal plasma flow increased significantly with ANF infusion. There was a significant fall in systolic blood pressure, with no apparent change in heart rate and diastolic blood pressure.
CONCLUSIONS: These results suggest that ANF may have beneficial effects in protecting against cyclosporin A-induced nephrotoxicity and hypertension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317909     DOI: 10.1097/00004872-199205000-00012

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

1.  The effect of ACE inhibitors and atrial natriuretic factor on the cardiorenal axis in man.

Authors:  A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

2.  Reciprocal regulation of cyclic GMP content by cyclic GMP-phosphodiesterase and guanylate cyclase in SHR with CsA-induced nephrotoxicity.

Authors:  N Hosogai; J Seki; T Goto
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 3.  Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?

Authors:  A D Struthers
Journal:  BMJ       Date:  1994-06-18

Review 4.  Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis.

Authors:  Sagar U Nigwekar; Sankar D Navaneethan; Chirag R Parikh; John K Hix
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 8.237

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.